External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Dermatology Fall CDC 2024
Roche and Genentech at

Fall CDC 2024

October 24 - October 27
Las Vegas, USA / Virtual (Hybrid)
dermsquared.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:00 PM
Duration 24hrs Las Vegas, USA
Phase III Clinical Trials for Omalizumab and Remibrutinib for Patients With Chronic Spontaneous Urticaria
Lebwohl M, Anders K, Seetasith A, Holden M
Dermatology | Chronic Idiopathic Urticaria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 24hrs Las Vegas, USA
Efficacy Outcomes in Phase III Trials for Omalizumab and Dupilumab for Patients With Chronic Spontaneous Urticaria
Alexis A, Anders K, Seetasith A, Holden M
Dermatology | Chronic Idiopathic Urticaria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.